{"entity":{"type":"insider","cik":"0001384192","url":"/insider/0001384192","json_url":"/insider/0001384192.json","name":"Marco Philippe H","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":159,"n_filings":17,"first":"2007-09-05","last":"2008-10-01","span_basis":"filed_date"},"name_variants":[{"name":"Marco Philippe H","source":"filing","n_filings":17,"first_seen":"2007-09-05","last_seen":"2008-10-01"}],"transactions":[{"id":3662107,"accession":"0001212235-08-000113","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-13","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":1890.0,"total_display":"1,890.00","shares_owned_after":71100.0,"shares_owned_after_display":"71,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662105,"accession":"0001212235-08-000113","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-12","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":1040.0,"total_display":"1,040.00","shares_owned_after":73600.0,"shares_owned_after_display":"73,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662104,"accession":"0001212235-08-000113","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-11","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":700.0,"total_display":"700.00","shares_owned_after":69900.0,"shares_owned_after_display":"69,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662103,"accession":"0001212235-08-000113","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-10","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":1.34,"price_display":"1.34","price_state":"stated","total_value":670.0,"total_display":"670.00","shares_owned_after":72500.0,"shares_owned_after_display":"72,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662102,"accession":"0001212235-08-000113","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-9","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":417.0,"total_display":"417.00","shares_owned_after":70400.0,"shares_owned_after_display":"70,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662101,"accession":"0001212235-08-000113","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-8","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":414.0,"total_display":"414.00","shares_owned_after":70700.0,"shares_owned_after_display":"70,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662100,"accession":"0001212235-08-000113","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-7","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":1.32,"price_display":"1.32","price_state":"stated","total_value":396.0,"total_display":"396.00","shares_owned_after":73200.0,"shares_owned_after_display":"73,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662099,"accession":"0001212235-08-000113","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-6","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":1.23,"price_display":"1.23","price_state":"stated","total_value":369.0,"total_display":"369.00","shares_owned_after":74500.0,"shares_owned_after_display":"74,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662098,"accession":"0001212235-08-000113","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-5","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":1.33,"price_display":"1.33","price_state":"stated","total_value":266.0,"total_display":"266.00","shares_owned_after":73000.0,"shares_owned_after_display":"73,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662097,"accession":"0001212235-08-000113","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-4","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":1.41,"price_display":"1.41","price_state":"stated","total_value":141.0,"total_display":"141.00","shares_owned_after":69800.0,"shares_owned_after_display":"69,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662096,"accession":"0001212235-08-000113","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-3","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":1.36,"price_display":"1.36","price_state":"stated","total_value":136.0,"total_display":"136.00","shares_owned_after":71000.0,"shares_owned_after_display":"71,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662095,"accession":"0001212235-08-000113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-2","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":1.31,"price_display":"1.31","price_state":"stated","total_value":131.0,"total_display":"131.00","shares_owned_after":73500.0,"shares_owned_after_display":"73,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3662094,"accession":"0001212235-08-000113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001212235-08-000113","line_url":"/filing/0001212235-08-000113#line-1","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":125.0,"total_display":"125.00","shares_owned_after":74400.0,"shares_owned_after_display":"74,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-01","filed_date":"2008-10-01","scope":"insider"},{"id":3568652,"accession":"0001212235-08-000112","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001212235-08-000112","line_url":"/filing/0001212235-08-000112#line-5","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400.0,"shares_display":"4,400","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":8800.0,"total_display":"8,800.00","shares_owned_after":75350.0,"shares_owned_after_display":"75,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-02","filed_date":"2008-09-02","scope":"insider"},{"id":3568650,"accession":"0001212235-08-000112","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001212235-08-000112","line_url":"/filing/0001212235-08-000112#line-4","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350.0,"shares_display":"350","price_per_share":2.01,"price_display":"2.01","price_state":"stated","total_value":703.5,"total_display":"703.50","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-02","filed_date":"2008-09-02","scope":"insider"},{"id":3568648,"accession":"0001212235-08-000112","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001212235-08-000112","line_url":"/filing/0001212235-08-000112#line-3","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":2.07,"price_display":"2.07","price_state":"stated","total_value":207.0,"total_display":"207.00","shares_owned_after":74800.0,"shares_owned_after_display":"74,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-02","filed_date":"2008-09-02","scope":"insider"},{"id":3568646,"accession":"0001212235-08-000112","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001212235-08-000112","line_url":"/filing/0001212235-08-000112#line-2","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":2.05,"price_display":"2.05","price_state":"stated","total_value":205.0,"total_display":"205.00","shares_owned_after":74900.0,"shares_owned_after_display":"74,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-02","filed_date":"2008-09-02","scope":"insider"},{"id":3568644,"accession":"0001212235-08-000112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001212235-08-000112","line_url":"/filing/0001212235-08-000112#line-1","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":98.5,"total_display":"98.50","shares_owned_after":79750.0,"shares_owned_after_display":"79,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-02","filed_date":"2008-09-02","scope":"insider"},{"id":2404534,"accession":"0001212235-08-000098","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001212235-08-000098","line_url":"/filing/0001212235-08-000098#line-5","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":5610.0,"total_display":"5,610.00","shares_owned_after":81000.0,"shares_owned_after_display":"81,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-01","filed_date":"2008-08-04","scope":"insider"},{"id":2404530,"accession":"0001212235-08-000098","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001212235-08-000098","line_url":"/filing/0001212235-08-000098#line-4","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":2600.0,"total_display":"2,600.00","shares_owned_after":79800.0,"shares_owned_after_display":"79,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-01","filed_date":"2008-08-04","scope":"insider"},{"id":2404522,"accession":"0001212235-08-000098","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001212235-08-000098","line_url":"/filing/0001212235-08-000098#line-3","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":2.57,"price_display":"2.57","price_state":"stated","total_value":257.0,"total_display":"257.00","shares_owned_after":80800.0,"shares_owned_after_display":"80,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-01","filed_date":"2008-08-04","scope":"insider"},{"id":2404517,"accession":"0001212235-08-000098","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001212235-08-000098","line_url":"/filing/0001212235-08-000098#line-2","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":2.56,"price_display":"2.56","price_state":"stated","total_value":256.0,"total_display":"256.00","shares_owned_after":80900.0,"shares_owned_after_display":"80,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-01","filed_date":"2008-08-04","scope":"insider"},{"id":2404513,"accession":"0001212235-08-000098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001212235-08-000098","line_url":"/filing/0001212235-08-000098#line-1","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":253.0,"total_display":"253.00","shares_owned_after":83200.0,"shares_owned_after_display":"83,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-01","filed_date":"2008-08-04","scope":"insider"},{"id":2672777,"accession":"0001212235-08-000094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001212235-08-000094","line_url":"/filing/0001212235-08-000094#line-1","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":2.43,"price_display":"2.43","price_state":"stated","total_value":8505.0,"total_display":"8,505.00","shares_owned_after":83300.0,"shares_owned_after_display":"83,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-01","filed_date":"2008-07-01","scope":"insider"},{"id":3838112,"accession":"0001212235-08-000062","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001212235-08-000062","line_url":"/filing/0001212235-08-000062#line-8","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":3.43,"price_display":"3.43","price_state":"stated","total_value":5831.0,"total_display":"5,831.00","shares_owned_after":88000.0,"shares_owned_after_display":"88,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-02","filed_date":"2008-06-03","scope":"insider"},{"id":3838111,"accession":"0001212235-08-000062","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001212235-08-000062","line_url":"/filing/0001212235-08-000062#line-7","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":3.56,"price_display":"3.56","price_state":"stated","total_value":1780.0,"total_display":"1,780.00","shares_owned_after":86800.0,"shares_owned_after_display":"86,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-02","filed_date":"2008-06-03","scope":"insider"},{"id":3838110,"accession":"0001212235-08-000062","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001212235-08-000062","line_url":"/filing/0001212235-08-000062#line-6","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":1360.0,"total_display":"1,360.00","shares_owned_after":89900.0,"shares_owned_after_display":"89,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-02","filed_date":"2008-06-03","scope":"insider"},{"id":3838108,"accession":"0001212235-08-000062","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001212235-08-000062","line_url":"/filing/0001212235-08-000062#line-5","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":3.52,"price_display":"3.52","price_state":"stated","total_value":704.0,"total_display":"704.00","shares_owned_after":87300.0,"shares_owned_after_display":"87,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-02","filed_date":"2008-06-03","scope":"insider"},{"id":3838105,"accession":"0001212235-08-000062","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001212235-08-000062","line_url":"/filing/0001212235-08-000062#line-4","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":700.0,"total_display":"700.00","shares_owned_after":87500.0,"shares_owned_after_display":"87,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-02","filed_date":"2008-06-03","scope":"insider"},{"id":3838104,"accession":"0001212235-08-000062","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001212235-08-000062","line_url":"/filing/0001212235-08-000062#line-3","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":3.45,"price_display":"3.45","price_state":"stated","total_value":690.0,"total_display":"690.00","shares_owned_after":87700.0,"shares_owned_after_display":"87,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-02","filed_date":"2008-06-03","scope":"insider"},{"id":3838101,"accession":"0001212235-08-000062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001212235-08-000062","line_url":"/filing/0001212235-08-000062#line-2","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":3.42,"price_display":"3.42","price_state":"stated","total_value":684.0,"total_display":"684.00","shares_owned_after":89700.0,"shares_owned_after_display":"89,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-02","filed_date":"2008-06-03","scope":"insider"},{"id":3838099,"accession":"0001212235-08-000062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001212235-08-000062","line_url":"/filing/0001212235-08-000062#line-1","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":3.44,"price_display":"3.44","price_state":"stated","total_value":344.0,"total_display":"344.00","shares_owned_after":87900.0,"shares_owned_after_display":"87,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-02","filed_date":"2008-06-03","scope":"insider"},{"id":3467857,"accession":"0001212235-08-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001212235-08-000059","line_url":"/filing/0001212235-08-000059#line-1","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":12250.0,"total_display":"12,250.00","shares_owned_after":89050.0,"shares_owned_after_display":"89,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-01","filed_date":"2008-05-01","scope":"insider"},{"id":4039588,"accession":"0001212235-08-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001212235-08-000046","line_url":"/filing/0001212235-08-000046#line-1","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":17500.0,"total_display":"17,500.00","shares_owned_after":92550.0,"shares_owned_after_display":"92,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-01","filed_date":"2008-04-02","scope":"insider"},{"id":3722691,"accession":"0001212235-08-000040","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-20","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":7.11,"price_display":"7.11","price_state":"stated","total_value":2844.0,"total_display":"2,844.00","shares_owned_after":97250.0,"shares_owned_after_display":"97,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722690,"accession":"0001212235-08-000040","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-19","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":6.86,"price_display":"6.86","price_state":"stated","total_value":2744.0,"total_display":"2,744.00","shares_owned_after":98950.0,"shares_owned_after_display":"98,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722689,"accession":"0001212235-08-000040","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-18","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":7.16,"price_display":"7.16","price_state":"stated","total_value":2148.0,"total_display":"2,148.00","shares_owned_after":96350.0,"shares_owned_after_display":"96,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722687,"accession":"0001212235-08-000040","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-17","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":2100.0,"total_display":"2,100.00","shares_owned_after":98150.0,"shares_owned_after_display":"98,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722686,"accession":"0001212235-08-000040","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-16","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.15,"price_display":"7.15","price_state":"stated","total_value":1430.0,"total_display":"1,430.00","shares_owned_after":96650.0,"shares_owned_after_display":"96,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722684,"accession":"0001212235-08-000040","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-15","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.14,"price_display":"7.14","price_state":"stated","total_value":1428.0,"total_display":"1,428.00","shares_owned_after":96850.0,"shares_owned_after_display":"96,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722683,"accession":"0001212235-08-000040","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-14","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.12,"price_display":"7.12","price_state":"stated","total_value":1424.0,"total_display":"1,424.00","shares_owned_after":97050.0,"shares_owned_after_display":"97,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722681,"accession":"0001212235-08-000040","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-13","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.01,"price_display":"7.01","price_state":"stated","total_value":1402.0,"total_display":"1,402.00","shares_owned_after":97950.0,"shares_owned_after_display":"97,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722680,"accession":"0001212235-08-000040","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-12","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":6.95,"price_display":"6.95","price_state":"stated","total_value":1390.0,"total_display":"1,390.00","shares_owned_after":98450.0,"shares_owned_after_display":"98,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722678,"accession":"0001212235-08-000040","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-11","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":7.49,"price_display":"7.49","price_state":"stated","total_value":749.0,"total_display":"749.00","shares_owned_after":96050.0,"shares_owned_after_display":"96,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722677,"accession":"0001212235-08-000040","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-10","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":7.3,"price_display":"7.30","price_state":"stated","total_value":730.0,"total_display":"730.00","shares_owned_after":96150.0,"shares_owned_after_display":"96,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722675,"accession":"0001212235-08-000040","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-9","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":7.18,"price_display":"7.18","price_state":"stated","total_value":718.0,"total_display":"718.00","shares_owned_after":96250.0,"shares_owned_after_display":"96,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722673,"accession":"0001212235-08-000040","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-8","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":7.1,"price_display":"7.10","price_state":"stated","total_value":710.0,"total_display":"710.00","shares_owned_after":97650.0,"shares_owned_after_display":"97,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722672,"accession":"0001212235-08-000040","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-7","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":707.0,"total_display":"707.00","shares_owned_after":97750.0,"shares_owned_after_display":"97,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722671,"accession":"0001212235-08-000040","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-6","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":7.06,"price_display":"7.06","price_state":"stated","total_value":706.0,"total_display":"706.00","shares_owned_after":97850.0,"shares_owned_after_display":"97,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"},{"id":3722670,"accession":"0001212235-08-000040","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001212235-08-000040","line_url":"/filing/0001212235-08-000040#line-5","is_derivative":false,"issuer_cik":"0001212235","issuer_name":"XTENT INC","issuer_ticker":"XTNT","issuer_name_source":null,"issuer_url":"/issuer/0001212235","owner_cik":"0001384192","owner_name":"Marco Philippe H","owner_url":"/insider/0001384192","role":"Officer (VP-QA, Clinical & Reg. Affairs)","officer_title":"VP-QA, Clinical & Reg. Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":6.93,"price_display":"6.93","price_state":"stated","total_value":693.0,"total_display":"693.00","shares_owned_after":98650.0,"shares_owned_after_display":"98,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-03","filed_date":"2008-03-04","scope":"insider"}],"next_cursor":"2008-03-03|3722670","ledger_fault":false,"count":{"value":159,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":159,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":159},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001212235","name":"XTENT INC","url":"/issuer/0001212235","role":"Officer (VP-QA, Clinical & Reg. Affairs)","n_filings":17,"first_seen":"2007-09-05","last_seen":"2008-10-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001384192","retrieved_at":"2026-08-21T22:53:09+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}